Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2026-01-05 @ 6:29 PM
Study NCT ID:
NCT03565003
Status:
COMPLETED
Last Update Posted:
2024-09-25
First Post:
2018-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
Sponsor:
Jacobio Pharmaceuticals Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JAB-3068-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None